TIAA CREF Individual & Institutional Services LLC Acquires 18,339 Shares of Stryker Corporation $SYK

TIAA CREF Individual & Institutional Services LLC acquired a new stake in Stryker Corporation (NYSE:SYK – Free Report) in the third quarter, HoldingsChannel.com reports. The firm acquired 18,339 shares of the medical technology company’s stock, valued at approximately $5,050,000.

Several other institutional investors have also recently added to or reduced their stakes in the business. Bank of America Corp DE purchased a new position in shares of Stryker during the 2nd quarter worth about $1,404,284,000. Legal & General Group Plc purchased a new stake in Stryker in the second quarter valued at approximately $707,212,000. Jupiter Topco LLC purchased a new stake in Stryker in the second quarter valued at approximately $681,581,000. Corient Private Wealth LP acquired a new position in Stryker during the second quarter worth approximately $323,035,000. Finally, Flossbach Von Storch SE acquired a new position in Stryker during the second quarter worth approximately $464,506,000. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Stryker Stock Performance

Stryker stock opened at $309.91 on Friday. The stock has a market cap of $117.98 billion, a P/E ratio of 33.00, a price-to-earnings-growth ratio of 2.13 and a beta of 0.78. The company has a current ratio of 2.18, a quick ratio of 1.30 and a debt-to-equity ratio of 0.60. The stock has a 50 day moving average of $295.66 and a 200-day moving average of $321.39. Stryker Corporation has a 52 week low of $267.00 and a 52 week high of $389.33.

Stryker (NYSE:SYK – Get Free Report) last posted its quarterly earnings data on Thursday, October 29th. The medical technology company reported $3.52 EPS for the quarter, missing analysts’ consensus estimates of $3.55 by ($0.03). The company had revenue of $6.52 billion for the quarter, compared to the consensus estimate of $6.62 billion. Stryker had a net margin of 13.78% and a return on equity of 23.74%. The company’s revenue was up 7.6% compared to the same quarter last year. During the same quarter last year, the company earned $3.19 earnings per share. On average, analysts expect that Stryker Corporation will post 14.85 EPS for the current fiscal year.

Insider Activity

In other news, Director Ronda Stryker sold 550,000 shares of the stock in a transaction dated Friday, November 6th. The shares were sold at an average price of $325.32, for a total transaction of $178,926,000.00. Following the transaction, the director owned 1,701,375 shares of the company’s stock, valued at approximately $553,491,315. This trade represents a 24.43% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 4.60% of the company’s stock.

Wall Street Analyst Weigh In

SYK has been the topic of a number of research analyst reports. Robert W. Baird decreased their price target on shares of Stryker from $385.00 to $334.00 in a report on Friday, October 30th. Johnson Rice downgraded Stryker to a “hold” rating in a report on Friday, October 30th. Evercore increased their target price on Stryker from $335.00 to $355.00 in a research report on Wednesday, October 28th. Citigroup reiterated a “market outperform” rating on shares of Stryker in a report on Friday, October 30th. Finally, Raymond James Financial reiterated an “outperform” rating and issued a $323.00 target price (down from $370.00) on shares of Stryker in a report on Friday, October 30th. Twenty-one investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat, Stryker has an average rating of “Moderate Buy” and a consensus price target of $343.77.

Check Out Our Latest Report on SYK

Stryker Profile

(Free Report)

Stryker is a medical technology company that develops and sells products and services for healthcare providers. Its offerings include orthopedic implants and surgical equipment, neurotechnology and spine products, and medical and surgical equipment used in hospitals and other care settings. The company’s products also include patient-handling and emergency medical equipment, as well as instruments and technologies that support surgical procedures. Stryker serves healthcare customers in the United States and internationally.

Recommended Stories

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK – Free Report).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.